“Nuclear Medicine and Radiopharmaceutical Manufacturing Market, 2020-2030”

A detailed -essment of the current market landscape with respect to the players (industry and non-industry) involved in manufacturing radiopharmaceuticals.

SHARE THIS POST :
“Nuclear Medicine and Radiopharmaceutical Manufacturing Market, 2020-2030” <Roots>

To order this detailed 320+ page report, please visit this - https://www.roots-ysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

Target Therapeutic Area

Cardiology

Neurology

Oncology

Thyroid

Others

Application Area

Diagnostic

Therapeutic

Type of Diagnostic Radiopharmaceuticals

PET

SPECT

Type of Therapeutic Radiopharmaceuticals

Alpha Emitters

Beta Emitters

Others

Purpose of Production

In-House

Outsourcing

Key Geographical Region 

North America

Europe

Asia-Pacific and the Rest of the World 

Transcripts of interviews held with the following senior level representatives of stakeholder companies

J James Davis, Vice President Quality / R&D, Shertech Laboratories

Andreas Fotopoulos, Professor of Nuclear Medicine, University of Ioannina Medical School

Jan Pruim, Professor of Medical Imaging / Nuclear Medicine Physician, University Medical Center of Groningen

Michael van Dam, Professor, Crump Ins-ute for Molecular Imaging, Molecular & Medical Pharmacology

Anonymous, ITM Isotopen Technologien München

To request sample pages, please visit this - https://www.roots-ysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing/request-sample.html